Go to deals
Food & Beverage | Healthcare

Naturex SA has acquired Swedish Oat Fiber AB

Naturex SA, the global leader in specialty plant-based natural ingredients, has acquired Swedish Oat Fiber AB, a specialized manufacturer of oat dietary fibers, oat oils and oat proteins. Financial details have not been disclosed.

Naturex sources, manufactures and markets natural specialty ingredients for the food, healthcare and cosmetic industries. Headquartered in Avignon, France, the group has experienced steadily increasing growth throughout the last 25 years. Naturex employs 1,700 people worldwide and had revenues of US$437 million in 2016.

Swedish Oat Fiber is a manufacturer with a key international position as a producer of oat beta-glucans dietary fibers, oat oils and oat proteins for the food industry, nutraceutical, cosmetic and animal feed applications. The company has 25 employees and an annual turnover of US$13.2 million.

Oaklins' teams in France and Sweden identified potential targets and advised the buyer on this transaction. This is another example of the strength of Oaklins' teams working together.

Parties

Talk to the deal team

Philippe Hermant

Senior Advisor
Paris, France
Oaklins France

Adel Koubaa

Managing Partner
Stockholm, Sweden
Oaklins Sweden

Lars Gustafsson

Partner
Stockholm, Sweden
Oaklins Sweden

Leïla Djebli

Director
Paris, France
Oaklins France

Related deals

ELSA Group has sold SoFine Foods to The New Originals Company
Food & Beverage

ELSA Group has sold SoFine Foods to The New Originals Company

The New Originals Company has acquired SoFine Foods from the ELSA Group.

Learn more
Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.
Healthcare

Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.

Dimainvest S.r.l. has initiated a voluntary public tender offer for the shares of Shedir Pharma Group S.p.A.

Learn more
Afric Phar has been acquired by Pharma Capital
Healthcare

Afric Phar has been acquired by Pharma Capital

Pharma Capital S.A. has acquired a significant stake in the Moroccan pharmaceutical group Afric Phar, which includes leading companies Afric Phar, Pharmis and Partner Lab, from the Chaoui family, in one of the largest transactions in the Moroccan pharmaceutical sector.

Learn more